Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

Shashikant Apte, MD FRCPA, Rajesh Phatale, MD, Aditi Joshi, BAMS, Kannan Subramanian, MD DM, MBBS

Blood (2018) 132 (Supplement 1): 4684.

https://doi.org/10.1182/blood-2018-99-116160

Published: 2018

Journal Articles

Good Care and Long-Term Follow-up in Young Hemophiliacs

Zeynep Iscan, MD, Basak Koc, MD, Onder Kilicoglu, Prof, Ata Atalar, Prof, Omer Taser, Prof, Gulten Cetik, Bulent Zulfikar, Prof

Blood (2018) 132 (Supplement 1): 5028.

https://doi.org/10.1182/blood-2018-99-117936

Published: 2018

Journal Articles

Use of "Big Data" to Define Disease Burden, Complication Rates and Healthcare Costs in Patients with Heparin Induced Thrombocytopenia (HIT)

Binod Dhakal, MDMS, Parameswaran Hari, MBBS, MD MRCP, Lisa Rein, MS, Raphael Fraser, PhD, Anand Padmanabhan, MBBS, MA, PhD

Blood (2016) 128 (22): 418.

https://doi.org/10.1182/blood.V128.22.418.418

Published: 2016

Journal Articles

Blood Management Strategies to Reduce Transfusions after Elective Lower-Extremity Joint Arthroplasty Surgeries: One Tertiary Care Hospital's Early Experience with an Alternative Payment Model - a Total Joint 'Bundle

Ankit J. Kansagra, MD, Saurabh Dahiya, MD, Chester Andrzejewski, PhD MD, Robert Krushell, MD, Andrew Lehman, MD, Jordan Greenbaum, MD, Alice Ehresman, RN, MBA, Paul Visintainer, PhD, Joan McGirr, BSN, RN, Kathleen Mahoney, MD MBA, Darlene Cloutier, MT(ASCP),HP, Mihaela Stefan, MD PhD

Blood (2016) 128 (22): 3854.

https://doi.org/10.1182/blood.V128.22.3854.3854

Published: 2016

Journal Articles

The Potential Role of Ferritin in Relation to Inflammatory and Metabolic Syndrome Biomarkers in Patients Undergoing Total Joint Arthroplasty of the Hip or Knee

Christopher Wanderling, Jeffrey Liles, Peter Carlsgaard, Jennifer Saluk, Daneyal Syed, Schnettler Timothy, MD, Nil Guler, MD, William Hopkinson, MD, Debra Hoppensteadt, PhD, Jawed Fareed, PhD

Blood (2015) 126 (23): 4560.

https://doi.org/10.1182/blood.V126.23.4560.4560

Published: 2015

Journal Articles

Total Hip Replacement in a Hemophilia-a Patient with High Titer Inhibitor

Zühre Kaya, Associate Professor, Özlem Orhan, Sacit Turanli, Profesor, Türkiz Gürsel, Professor, Ulker Kocak, MD, Idil Yenicesu, Professor

Blood (2015) 126 (23): 4707.

https://doi.org/10.1182/blood.V126.23.4707.4707

Published: 2015

Journal Articles

A Systematic Review of the Classification, Diagnosis, Treatment and Outcome of Osteonecrosis of the Hips in Sickle Cell Disease

Dalal Hamza Mulla-Ali, BCh, BAO, LRCPSI, FRCPC, Kevin H.M. Kuo, MD MSc, FRCPC, Ambica Parmar, MD, Yves D. Pastore, MD

Blood (2015) 126 (23): 2069.

https://doi.org/10.1182/blood.V126.23.2069.2069

Published: 2015

Journal Articles

Prevalence of Symptomatic Avascular Necrosis and the Operative Treatment in Adult Patients with Sickle Cell Disease

Morey A. Blinder, MD, Sarah Russel, Mikala Barnes, MA

Blood (2014) 124 (21): 1379.

https://doi.org/10.1182/blood.V124.21.1379.1379

Published: 2014

Journal Articles

Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study

Sam Schulman, MD, PhD, James Douketis, Rebecca Barty, MLT, BA, MSc(c), Agnes Y.Y. Lee, MD, MSc, FRCPC, Marc Carrier, MD, MSc, Fred Spencer, M.D., Mark D. Blostein, M.D., Susan Solymoss, MD, Sudeep Shivakumar, MD, BSc, Grace Wang, MMath, Nancy Heddle, MSc

Blood (2013) 122 (21): 3637.

https://doi.org/10.1182/blood.V122.21.3637.3637

Published: 2013

Journal Articles

Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty

John Murnaghan, MD, MSc, MA, FRCSC, Yulia Lin, MD, Helen Razmjou, PhD, Jeffrey Gollish, MD, Deborah Murnaghan, RN

Blood (2012) 120 (21): 1181.

https://doi.org/10.1182/blood.V120.21.1181.1181

Published: 2012

Journal Articles

Practical Experience of Thromboprophylaxis After Lower Limb Replacement – Rivaroxaban Versus Enoxaparin

Kyoung Ha Kim, Nam Seok Ham, Yang Ki Kim, Hyung Suk Choi, You Sung Suh, Young Woo Jeon, Han Jo Kim, Se Hyung Kim, Sang Byung Bae, Sung Kyu Park, MD.PhD., Jong-Ho Won, Dae Sik Hong, Hee Sook Park

Blood (2012) 120 (21): 4369.

https://doi.org/10.1182/blood.V120.21.4369.4369

Published: 2012

Journal Articles

Thromboembolic and Bleeding Events Following Elective Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor

John Murnaghan, MD, Jeffrey Gollish, MD, Deborah Murnaghan, RN, Helen Razmjou, PhD, Andrea Donovan, MD, Vikas Bansal, MD

Blood (2012) 120 (21): 501.

https://doi.org/10.1182/blood.V120.21.501.501

Published: 2012

Journal Articles

Importance of Individualized Replacement of Factor VIII Concentrate According to Recovery Test in Hemophilia A Patient During Surgery

Ye Jee Shim, M.D., Yong-Mook Choi, M.D., Ji Yoon KIm, M.D., Kun Soo Lee, M.D.

Blood (2011) 118 (21): 4654.

https://doi.org/10.1182/blood.V118.21.4654.4654

Published: 2011

Journal Articles

Thrombin Generation Assay and by-Passing Therapies in Patients with Inhibitors,

Kaan Kavakli, MD, Yilmaz Ay, MD, Deniz Yilmaz Karapinar, MD, Can Balkan, MD

Blood (2011) 118 (21): 3322.

https://doi.org/10.1182/blood.V118.21.3322.3322

Published: 2011

Journal Articles

Hemostatic Outcomes of Hip and Knee Joint Replacement Surgery in Von Willebrand Disease (VWD) Patients: A Single Center Study

Rajiv Pruthi, MBBS, William L. Nichols, Jr., MD, Lucia Rugeri, MD

Blood (2011) 118 (21): 2279.

https://doi.org/10.1182/blood.V118.21.2279.2279

Published: 2011

Journal Articles

Hemostatic Challenges In Patients Treated with Eltrombopag

Michael D. Tarantino, MD, Patrick F. Fogarty, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 2511.

https://doi.org/10.1182/blood.V116.21.2511.2511

Published: 2010

Journal Articles

Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B

Giuseppe Tagariello, Alfonso Iorio, Pier M. Mannucci

Blood (2009) 114 (23): 4907–4908.

https://doi.org/10.1182/blood-2009-09-244566

Published: 2009

Journal Articles

Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders

Giuseppe Tagariello, Alfonso Iorio, Elena Santagostino, Massimo Morfini, Ruggero Bisson, Massimo Innocenti, Maria Elisa Mancuso, Maria Gabriella Mazzucconi, Gian Luigi Pasta, Paolo Radossi, Giuseppina Rodorigo, Cristina Santoro, Roberto Sartori, Antonio Scaraggi, Luigi Pier Solimeno, Pier Mannuccio Mannucci

Blood (2009) 114 (4): 779–784.

https://doi.org/10.1182/blood-2009-01-195313

Published: 2009

Journal Articles

Is VIII worse than IX?

Michael Makris

Blood (2009) 114 (4): 750–751.

https://doi.org/10.1182/blood-2009-04-217075

Published: 2009

Journal Articles

Analysis of Increased Blood Transfusions in U.S. Hospitals, 1997 – 2006.

Chaya T. Merrill, MPH, DrPH(c), Jeffery L Miller, MD, Claudia Steiner, MD, MPH

Blood (2008) 112 (11): 1302.

https://doi.org/10.1182/blood.V112.11.1302.1302

Published: 2008

NARROW

Bilateral, Simultaneous Total Knee Replacement (TKR) Surgery for Hemophilia a with Eloctate (Extended Half Life Product)—A Feasible and Cost Effective Approach

Good Care and Long-Term Follow-up in Young Hemophiliacs

Use of "Big Data" to Define Disease Burden, Complication Rates and Healthcare Costs in Patients with Heparin Induced Thrombocytopenia (HIT)

Blood Management Strategies to Reduce Transfusions after Elective Lower-Extremity Joint Arthroplasty Surgeries: One Tertiary Care Hospital's Early Experience with an Alternative Payment Model - a Total Joint 'Bundle

The Potential Role of Ferritin in Relation to Inflammatory and Metabolic Syndrome Biomarkers in Patients Undergoing Total Joint Arthroplasty of the Hip or Knee

Total Hip Replacement in a Hemophilia-a Patient with High Titer Inhibitor

A Systematic Review of the Classification, Diagnosis, Treatment and Outcome of Osteonecrosis of the Hips in Sickle Cell Disease

Prevalence of Symptomatic Avascular Necrosis and the Operative Treatment in Adult Patients with Sickle Cell Disease

Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study

Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty

Practical Experience of Thromboprophylaxis After Lower Limb Replacement – Rivaroxaban Versus Enoxaparin

Thromboembolic and Bleeding Events Following Elective Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor

Importance of Individualized Replacement of Factor VIII Concentrate According to Recovery Test in Hemophilia A Patient During Surgery

Thrombin Generation Assay and by-Passing Therapies in Patients with Inhibitors,

Hemostatic Outcomes of Hip and Knee Joint Replacement Surgery in Von Willebrand Disease (VWD) Patients: A Single Center Study

Hemostatic Challenges In Patients Treated with Eltrombopag

Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B

Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders

Is VIII worse than IX?

Analysis of Increased Blood Transfusions in U.S. Hospitals, 1997 – 2006.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only